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Total Hip Arthroplasty in a Low-Income Country
Ten-Year Outcomes from the National Joint Registry
of the Malawi Orthopaedic Association
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Investigation performed at Beit CURE International Hospital, Blantyre, Malawi
Background: We describe our 10-year experience performing total hip arthroplasty (THA) in patients enrolled in the
National Joint Registry of the Malawi Orthopaedic Association.
Methods: Eighty-three THAs were performed in 70 patients (40 male and 30 female) with a mean age of 52 years (range,
18 to 77 years). The cohort included 24 patients (14 male and 10 female; mean age, 52 years [range, 35 to 78 years])
who were human immunodeﬁciency virus (HIV)-positive.
Results: The main indications for surgery were osteonecrosis (n = 41 hips) and osteoarthritis (n = 26 hips). There were
no deaths perioperatively and no early complications at 6 weeks. Forty-six patients (59 THAs) were seen at 10 years
postoperatively, with a mean Harris hip score (HHS) of 88 (range, 41 to 91) and a mean Oxford Hip Score (OHS) of 46
(range, 25 to 48). Five hips (8% of 59) were revised due to loosening (n = 4) and fracture (n = 1). There were no infections or
dislocations. Fourteen patients died, including 4 HIV-positive patients, of unknown causes in the follow-up period, and 10
patients were lost to follow-up. In the group of 24 HIV-positive patients, there were no early complications, and the mean
HHS was 88 (range, 76 to 91) at >10 years.
Conclusions: Our 10-year experience and long-term outcomes after primary THA in a low-income setting show that good
results can be achieved within a controlled hospital environment, thereby establishing a benchmark against which other
hospitals and registries in similar low-income countries can compare their results.
Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
T
otal joint arthroplasty (TJA) is increasingly performed in
low-income countries, such as Malawi in sub-Saharan
Africa1-3. The reasons for this include, among other fac-
tors, greater surgical resources and longer life expectancy2.
However, many of these countries do not have adequate re-
sources to offer this form of service to all potential patients
who require or will beneﬁt from it4. Indications for surgery and
the age of the patient can be considerably different than in high-
income settings, with a larger proportion of patients with human
immunodeﬁciency virus (HIV)1. The training of surgeons and
allied health professionals, available facilities, and resources can
also differ substantially2. To our knowledge, long-term outcomes
and survivorship of TJA performed in low-income countries
have not previously been reported.
Beit CURE International Hospital (BCIH), where the
majority of the procedures recorded in the National Joint
Registry of the Malawi Orthopaedic Association (NJRMOA)
take place, is an example of a health-care system in which the
hospital provides scheduled hip and knee arthroplasty services
that, in turn, fund other health-care services that are provided
for free. The NJRMOAwas set up in 2005 to ensure that patients
undergoing TJA received follow-up and that surgical and
functional outcomes were accurately recorded for the purposes
of both clinical governance and research. The registry includes
every patient who has undergone TJA at Beit CURE.
Our primary objective was to describe what we believe to
be the ﬁrst study of total hip arthroplasty (THA) in a low-income
country to assess complications, patient-reported outcomes,
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and survivorship data extending over 10 years. Our hope is that
our ﬁndings will provide a benchmark against which other
hospitals and registries based in similar jurisdictions can com-
pare their outcomes.
Materials and Methods
All patients who underwent THA during the period ofJanuary 2005 to February 2008 were identiﬁed from the
NJRMOA and included in the study. All data were derived from
the registry, which was set up with ethical approval from the
Research and Ethics Committee of the College of Medicine of
the University of Malawi.
THA was performed on 83 hips in 70 patients (40 male
and 30 female) with a mean age of 52 years (range, 18 to 77
years); bilateral THAwas performed in 13 patients. The main
indications for surgery in the cohort as a whole were osteo-
necrosis (n = 41 hips) and osteoarthritis (n = 26 hips) (Table
I). The cohort included 24 HIV-positive patients (14 male and
10 female) with a mean age of 52 years (range, 35 to 78 years)
who underwent THA primarily because of osteonecrosis
(Table II).
The procedures were performed by 6 surgeons at 3
institutions, with most procedures (66, 80%) performed at
BCIH. No operating theater had a laminar ﬂow system. Two
different all-cemented prostheses with well-established good
long-term survivorship were used5-7: a Charnley prosthesis
(DePuy Orthopaedics) with either a ﬂanged or round-backed
femoral stem and a standard long posterior wall or an Ogee
acetabular component (DePuy) in 61 (73%) of the procedures,
and a Stanmore implant with modular stems and 28-mm
cobalt-chromium head (Biomet) in 22 (27%) of the proce-
dures. Implants were secured using SMARTSET GHV cement
with gentamicin (DePuy). At the start of surgery, patients also
received a single dose of cefuroxime intravenous antibiotic,
replaced by gentamicin in those allergic to penicillin. HIV-positive
patients were administered antibiotic prophylaxis along with
co-trimoxazole (trimethoprim-sulfamethoxazole) (960 mg),
in accordance with Malawi national policy and World Health
Organization guidelines8.
Patients were mobilized on the ﬁrst postoperative day and
used thromboembolism-deterrent graduated-compression
stockings along with low-dose aspirin for the following
6 weeks.
Postoperatively, at 6 weeks, 3 and 6months, and annually
thereafter, a senior research nurse in partnership with a senior
surgeon evaluated all patients for pain, postoperative compli-
cations, and function. Outcome measures include the Oxford
Hip Score (OHS) and the Harris hip score (HHS)9. However,
use of the OHS as a patient-reported outcome was introduced
after 2013, and therefore, preoperative scores are not available
for comparison. Furthermore, although the HHS was collected
preoperatively as of 12 months following the commencement
of the registry, the data are incomplete and preoperative values
are not reported in this study.
Surgical wounds were assessed in the ﬁrst 6 weeks using
the ASEPSIS system (Additional treatment, the presence of
Serous discharge, Erythema, Purulent exudate, and Separation
of the deep tissues, the Isolation of bacteria, and the duration of
inpatient Stay), which assigns a total possible score of 70 on the
basis of appearance and any additional treatment required10.
For the purpose of the present study, we considered a score of
>10 as indicative of early surgical site infection, a threshold
approved by the National Institute for Health and Care Ex-
cellence in the U.K11. Late wound infection was diagnosed if
there was wound breakdown or sinus formation >6 weeks
postoperatively, or unexplained late pain with associated radio-
graphic changes consistent with periprosthetic joint infection or
TABLE I Demographic and Surgical Data of Patients in the
Malawi National Joint Registry Who Underwent
THA During the Study Period
Demographic and Surgical Data No. of Patients (Hips)
Entered in registry 70 (83)
Lost to follow-up 10
10-yr follow-up in registry 46
Died 14
HIV-positive 24
HIV-negative 46
Indication for surgery
Osteonecrosis (41)
Osteoarthritis (26)
Previous infection (9)
Fractured neck of femur (2)
Failure of internal ﬁxation (1)
Other (4)
Type of implant
Charnley (61)
Stanmore (22)
TABLE II Demographic and Surgical Data of HIV-Positive
Patients in the Malawi National Joint Registry
Who Underwent THA During the Study Period
Demographic and Surgical Data No. of Patients
Entered in registry 24
Lost to follow-up 0
10-yr follow-up in registry 24
Indication for surgery
Osteonecrosis 16
Osteoarthritis 3
Previous infection 3
Other 2
Type of implant
Charnley 14
Stanmore 10
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microbiological conﬁrmation following revision surgery, irri-
gation, or aspiration.
Anteroposterior and lateral radiographs of the hip were
made at each follow-up appointment. The most recent radio-
graphs were reviewed by the ﬁrst author (S.M.G.), who had not
been involved in the surgical procedures and who assessed the
images for signs of loosening. For all HIV-positive patients,
antiretroviral therapy was administered according to national
guidelines.
Results
Of the 70 patients who underwent primary THA, 24 wereunavailable at the most recent follow-up and were excluded
from analysis. Of these 24 patients, 14 (20% of the original
cohort) had died, including 4 HIV-positive patients, before the
most recent follow-up and 10 (14%) were lost to follow-up,
leaving 46 patients (66%; 59 THAs) included in the ﬁnal
analysis of 10-year outcomes after primary THA. No accurate
recorded information was available for reporting the outcomes
of the patients who had died; however, none are thought to
have died as a result of their procedure or from complications
of their procedure.
All patients were seen at 6 weeks postoperatively. There
were no early complications, including deep vein thrombosis,
pulmonary embolism, or surgical site infection. This was re-
ﬂected by the fact that no patient had an ASEPSIS score of >10.
Overall, 5 revision procedures (5 of 59 THAs, 8%) were
performed, for aseptic loosening (n = 4) and a periprosthetic
fracture (n = 1); the latter patient underwent successful revi-
sion in India following the fracture, which occurred 5 years
after the primary procedure. All 5 patients who had revision
surgery, including 2 HIV-positive patients, are alive and are
currently being followed >10 years after the primary proce-
dure. No revision procedures had been performed among the
patients who died or were lost to follow-up.
Of the 4 revision procedures carried out for aseptic
loosening, 1 patient had a single-component acetabular revi-
sion 9 years postoperatively, 2 patients had both components
revised for loosening 9 years after the primary procedure, and
the fourth patient, who had undergone THA for trauma, had
revision of both components 5 years after the primary proce-
dure because of loosening and a re-revision for loosening 7
years after the primary procedure. Samples from both of these
procedures were taken, but no organism was grown on culture
to suggest low-grade infection. There were no revision proce-
dures for periprosthetic joint infection and no evidence of
infection in any of the patients who underwent revision. There
were also no revision procedures performed for instability or
dislocation and no signs of loosening on radiographs in the
patients without revision.
Hip scores were recorded for 36 and 46 patients at 5 and
10 years of follow-up, respectively. Additional OHS and HHS
data were available in the registry for 18 patients (26% of the
original cohort) who had >10 years of follow-up (Table III).
There was a decline seen in the HHS at 10 and >10 years and in
the OHS at >10 years. The scores were comparable with those
of other series at the same time points from high-income set-
tings and are above the scores correlating with the suggested
need for revision surgery12-14.
Discussion
We believe that our study is the ﬁrst to present long-termfollow-up data of patients who have undergone primary
THA in a low-income country. Our aim was to provide a
benchmark for use by other hospitals and registries in similar
settings when evaluating their own data. In particular, our
study is the ﬁrst, to our knowledge, to report 10-year follow-up
data of a cohort of HIV-positive patients who have undergone
THA, with most reports for this population focusing on peri-
operative complications and infections15-17. The perioperative
mortality rate was 0%, and there were no early complications at
6 weeks. An overall revision rate of 8% at 10 years and func-
tional scores that were good at 5 years and fair at 10 years
indicate good long-term survivorship9.
Two-thirds of the world’s population is estimated to live in
lower-middle and low-income countries, and arthritis ranks as
the eleventh highest contributor to global disability3. Arthro-
plasty, in some form, is becoming increasingly available in most
African countries, with reported results from South Africa,
Senegal, Kenya, Malawi, Zambia, Botswana, Burkina Faso, and
the Maghreb1,2,15,18-20, most of which are deﬁned as middle-
income countries21. There is, however, a paucity of literature
from low-income countries, with studies of small cohorts
focusing on perioperative and short-term complications.
Of 6 identiﬁed reports on THAs performed in low-
income countries15,18,22-25, 1 was a case series from Burkina Faso
that included 136 patients who underwent THA after an
arthroplasty service was initiated by a visiting surgical pro-
gram; a high intraoperative complication rate of 51% and a
perioperative complication rate of 16% were reported22. Only
1 paper, from Senegal, had follow-up of >18 months: 38
patients were followed for a maximum of 5 years after THA for
sickle cell disease; the complication rate was 19%24. To our
knowledge, no country other than Malawi has produced results
beyond 5 years. Our longest follow-up duration previously
reported from Malawi was a mean of 3.5 years15.
Both the population and indications for THA differ from
those in higher-income countries: our registry showed that 58%
TABLE III Postoperative Harris Hip Score (HHS) and Oxford
Hip Score (OHS) Results
Follow-up (yr) No. of Patients
Mean (Range)
HHS OHS
2 16 86 (44-91) 46 (32-48)
5 36 97 (36-91) 47 (36-48)
10 46 88 (41-91) 46 (25-48)
>10* 18 75 (44-91) 40 (9-48)
*Mean follow-up, 10.9 years.
Total Hip Arthroplasty in a Low-Income Country
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of the procedures were performed in men, and the average age
was 52 years, compared with 40% men, average age of 68 years,
in the U.K. This may well have implications on results, with
national registries showing higher revision rates among younger
patients26. The indications for THA are also poorly reported in
low-income countries. Osteoarthritis is responsible for 92% of
all hip replacements in the U.K. compared with 31% in Malawi,
where osteonecrosis is the leading indication, at 49%. Fractures
account for 2% of procedures in Malawi and 5% in the U.K27.
Our study showed promising results, with outcomes
comparable with those of the national joint registries of high-
income countries27. Ten-year mortality was 20% compared
with 25% in the U.K., no doubt reﬂecting the younger cohort in
the Malawi registry, although life expectancy is notably less
than the U.K28. Overall revision rates are similar: 8% at 10 years
compared with 5% in the U.K., a ﬁgure that climbs to 8%
among those <55 years of age, matching the younger Malawi
cohort27. One might expect infection and dislocation to rep-
resent notable complications in the short and long term for
THA in low-income countries; however, in our study, neither
of these complications was recorded. The mean HHS of 75 and
OHS of 40 at >10 years in our cohort compare favorably with
functional outcomes in high-income countries29. Functional
scores were even better in the HIV-positive cohort, with amean
HHS of 88 (range, 76 to 91) at >10 years. Reasons for this are
not clear, but possible explanations from our experience are the
younger, more active population seen in the Malawian cohort.
The main limitations of our study were the relatively small
number of patients included and the loss to follow-up. Follow-up
of patients in this environment can be challenging. Our hospital
is 1 of only 3 in the country at which TJA is performed. There-
fore, patients commonly live long distances from the hospital,
making follow-up challenging and costly for the patient. Fur-
thermore, since there is a lack of arthroplasty services in neigh-
boring countries, some of our patients do not live in Malawi,
again resulting in challenges with follow-up. In addition, despite
the small number of patients reported as having ‡10 years of
follow-up, we believe that this is the largest study of this type with
this length of follow-up from a low-income country in Africa.
Our institute provides only a private, elective hip and knee
arthroplasty service, which subsequently funds free orthopaedic
health care for children. Therefore, this limits the number of
arthroplasty procedures performed each year because the ser-
vices are only available through private or insurance funding.
Our 10-year experience of THA within a controlled
hospital environment in a low-income setting has demon-
strated that our encouraging early results can be sustained in
the long term. We previously called for other institutes and
low-income countries in our region to establish joint regis-
tries30. Comparative registries will highlight strengths and
weaknesses in different forms of arthroplasty services. They can
also help to focus training or adjustment of clinical practice,
and thus optimize good clinical governance for TJA in the
region. Furthermore, pooling the data may allow conclusions
about long-term outcomes to be derived earlier. n
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